Index | Parameter | Value | Units | Description |
1 |
| 10 | cells/mm3 day | Target cell type 1 source rate |
2 |
| 0.03198 | cells/mm3 day | Target cell type 2 source rate |
3 |
| 0.01 | 1/day | Target cell type 1 death rate |
4 |
| 0.01 | 1/day | Target cell type 2 death rate |
5 |
|
| mm3/virions day | Population 1 infection rate |
6 |
| 0.1 | mm3/virions day | Population 2 infection rate |
7 |
| 0.01 | mm3/cells day | Immune-induced clearance rate for population 1 |
8 |
| 0.01 | mm3/cells day | Immune-induced clearance rate for population 2 |
9 |
| 1 | virions/cell | Average number virions infecting a type 1 cell |
10 |
| 1 | virions/cell | Average number virions infecting a type 2 cell |
11 |
| 0.7 | 1/day | Infected cell death rate |
12 |
| 13 | 1/day | Virus natural death rate |
13 |
|
|
| Treatment efficacy reduction in population 2 |
14 |
| 100 | virions/cell | Virions produced per infected cell |
15 |
| .001 | cells/mm3 day | Immune effector production (source) rate |
16 |
| 0.1 | 1/day | Natural death rate for immune effectors |
17 |
| 0.3 | 1/day | Maximum birth rate for immune effectors |
18 |
| 0.25 | 1/day | Maximum death rate for immune effectors |
19 |
| 100 | cells/ml | Saturation constant for immune effector birth |
20 |
| 500 | cells/ml | Saturation constant for immune effector death |
21 |
|
|
| RTI efficacy |
22 |
|
|
| PI efficacy |